Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2026-09-15 06:33:04 ET · period of report 2026-09-14 · accession 0001878313-26-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 06:33 | 2026-09-14 | MAIA | Vitoc Vlad | CEO, Dir, 10% | P - Purchase | $1.37 | +73.0K | 1.05M | +7% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-14 | P | A | 73,000 | $1.37 | 1,049,121 | D | — | — |